Literature DB >> 2054769

Consensus conference on Lyme disease.

.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 2054769      PMCID： PMC1335531     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  7 in total

Review 1.  The emergence of Lyme disease in Canada.

Authors:  Nicholas H Ogden; L Robbin Lindsay; Muhammad Morshed; Paul N Sockett; Harvey Artsob
Journal:  CMAJ       Date:  2009-06-09       Impact factor: 8.262

2.  Active and passive surveillance and phylogenetic analysis of Borrelia burgdorferi elucidate the process of Lyme disease risk emergence in Canada.

Authors:  Nicholas H Ogden; Catherine Bouchard; Klaus Kurtenbach; Gabriele Margos; L Robbin Lindsay; Louise Trudel; Soulyvane Nguon; François Milord
Journal:  Environ Health Perspect       Date:  2010-03-25       Impact factor: 9.031

3.  Environmental risk from Lyme disease in central and eastern Canada: a summary of recent surveillance information.

Authors:  N H Ogden; J K Koffi; Y Pelcat; L R Lindsay
Journal:  Can Commun Dis Rep       Date:  2014-03-06

4.  Assessment of a screening test to identify Lyme disease risk.

Authors:  N H Ogden; J K Koffi; L R Lindsay
Journal:  Can Commun Dis Rep       Date:  2014-03-06

5.  Evolving perspectives on lyme borreliosis in Canada.

Authors:  Jlh Sperling; Mj Middelveen; D Klein; Fah Sperling
Journal:  Open Neurol J       Date:  2012-10-05

6.  Epidemiology of Lyme Disease, Nova Scotia, Canada, 2002-2013.

Authors:  Todd F Hatchette; B Lynn Johnston; Emily Schleihauf; Angela Mask; David Haldane; Michael Drebot; Maureen Baikie; Teri J Cole; Sarah Fleming; Richard Gould; Robbin Lindsay
Journal:  Emerg Infect Dis       Date:  2015-10       Impact factor: 6.883

7.  Current and future distribution of Ixodes scapularis ticks in Québec: Field validation of a predictive model.

Authors:  Marion Ripoche; Catherine Bouchard; Alejandra Irace-Cima; Patrick Leighton; Karine Thivierge
Journal:  PLoS One       Date:  2022-02-03       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.